Stem cell patch may result in improved function following heart attack

Nov 15, 2010

University of Cincinnati (UC) researchers have found that applying a stem cell-infused patch together with overexpression of a specific cell instruction molecule promoted cell migration to damaged cardiac tissue following heart attack and resulted in improved function in animal models.

The researchers also found that function improved more so than when were directly injected in heart tissue—a therapy that is being studied elsewhere.

These findings are being presented for the first time at the American Heart Association's Scientific Meeting in Chicago on Nov. 15.

Researchers in the department of pathology and laboratory medicine led by Yi-Gang Wang, PhD, found that when a tri-cell patch, made up of cardiomyocytes (to restore heart contractility), endothelial cells (to build new blood vessels) and embryonic fibroblasts (to provide support to the cell structure), was applied to the surface of the damaged area of the heart, better outcomes in overall heart function resulted.

"Following myocardial infarction, better known as , tissue becomes damaged and scarred, cardiomyocytes die and heart pump function is reduced," Wang says. "There are therapies being tested by other researchers where stem cells are injected directly into damaged heart muscle to see if contractile function can be restored.

"In our current study, we wanted to determine if the amplified instructions from overexpressed miR-29, a microRNA, in animal models would enhance the effectiveness of the cell patch by reducing barriers in the infarcted area, leading to enhanced regeneration of heart tissues and resulting in the restoration of heart function after myocardial infarction."

Researchers first generated cardiac progenitor cells—cells that can become various cell types—from induced pluripotent stem cells (iPSC). These can differentiate into any type of cell in the body and are artificially derived from non-pluripotent cells by inducing a forced expression of a number of desired genes.

The iPSC were then combined with specific heart tissue promoters to generate the desired cells. These cells were also labeled with green fluorescent protein (GFP) and firefly luciferase (a glowing laboratory reagent) to help with tracing and proliferation into the animal's system.

Researchers injected either the virus-mediated miR29b or a control material into the heart of the animal model and then experimentally induced a heart attack.

"These models allowed us to determine the possible benefits of miR29b and outcomes observed in two different control groups," Wang says.

Three days following the heart attack, researchers placed a cell patch on the damaged region and measured the expression of cardiac-related transcription factor A (a protein that binds to specific DNA sequences, controlling the movement of genetic information from DNA to mRNA), collagen levels in the damaged tissue and scar formation-related signaling pathways.

One month after the cell patch implantation, echocardiograms were performed to evaluate heart function.

"The mobilization of cells into the infarcted region of the heart was then analyzed by counting the number of GFP cells and by bioluminescence imaging (BLI) of cells with firefly luciferase, an imaging technology where the ongoing biological processes are visualized," Wang says.

Researchers found the number of GFP cells, BLI signals and heart function as a whole significantly increased in animals with the viral transfer that overexpressed miR-29b and were treated with the tri-cell patch.

"These findings show that an overexpression of miR-29 results in heart tissue changes that favor enhanced mobilization of desired cell types into infarct regions after heart attack, leading to improved ," he says. "Hopefully, one day such treatments will restore cardiac function in patients who have experienced a heart attack, leading to a longer and better quality of life."

Explore further: Serotonin neuron subtypes: New insights could inform SIDS understanding, depression treatment

Provided by University of Cincinnati Academic Health Center

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Stem cells to repair damaged heart muscle

Jun 22, 2007

In the first trial of its kind in the world, 60 patients who have recently suffered a major heart attack will be injected with selected stem cells from their own bone marrow during routine coronary bypass surgery.

Adult pig stem cells repair heart damage

Nov 14, 2006

U.S. scientists have successfully grown large numbers of stem cells from adult pigs' heart tissue and used the cells to repair heart attack damage.

Heart derived stem cells develop into heart muscle

Apr 23, 2008

Dutch researchers at University Medical Center Utrecht and the Hubrecht Institute have succeeded in growing large numbers of stem cells from adult human hearts into new heart muscle cells. A breakthrough in stem cell research. ...

Recommended for you

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.